Anemia in Chronic Kidney Disease Patients

A. Rastogi, A. Nissenson
{"title":"Anemia in Chronic Kidney Disease Patients","authors":"A. Rastogi, A. Nissenson","doi":"10.1111/J.1778-428X.2005.TB00119.X","DOIUrl":null,"url":null,"abstract":"SUMMARY \n \nAnemia is a common and early complication of chronic kidney disease (CKD) and is associated with a wide range of complications including increased morbidity and mortality due to cardiovascular consequences. Several factors contribute to the anemia seen in CKD patients but by far the most important factor is erythropoietin deficiency. The anemia of CKD remains both underdiagnosed and undertreated despite the wide availability of safe and effective treatment. Correction of anemia with exogenous erythropoietin is associated with improvements in outcome and hence should be aggressively pursued. Iron deficiency is common in CKD patients for multiple reasons and should be appropriately treated prior to erythropoietin treatment.","PeriodicalId":90375,"journal":{"name":"Transfusion alternatives in transfusion medicine : TATM","volume":"6 1","pages":"5-13"},"PeriodicalIF":0.0000,"publicationDate":"2008-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/J.1778-428X.2005.TB00119.X","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion alternatives in transfusion medicine : TATM","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/J.1778-428X.2005.TB00119.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

SUMMARY Anemia is a common and early complication of chronic kidney disease (CKD) and is associated with a wide range of complications including increased morbidity and mortality due to cardiovascular consequences. Several factors contribute to the anemia seen in CKD patients but by far the most important factor is erythropoietin deficiency. The anemia of CKD remains both underdiagnosed and undertreated despite the wide availability of safe and effective treatment. Correction of anemia with exogenous erythropoietin is associated with improvements in outcome and hence should be aggressively pursued. Iron deficiency is common in CKD patients for multiple reasons and should be appropriately treated prior to erythropoietin treatment.
慢性肾病患者的贫血
贫血是慢性肾脏疾病(CKD)常见的早期并发症,并与多种并发症相关,包括心血管后果导致的发病率和死亡率增加。多种因素导致慢性肾病患者出现贫血,但迄今为止最重要的因素是促红细胞生成素缺乏。尽管安全有效的治疗方法广泛可用,但慢性肾病的贫血仍未得到充分的诊断和治疗。用外源性促红细胞生成素矫正贫血与预后改善有关,因此应积极追求。由于多种原因,缺铁在慢性肾病患者中很常见,在接受促红细胞生成素治疗前应适当治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信